Clinical trials for patients with Peripheral Arterial or Vascular Disease (PAD)
The Texas Heart Institute Stem Cell Center in Houston, Texas is actively screening eligible patients for a clinical study for patients who have been diagnosed with PAD. This study is called PACE (Patients with Intermittent Claudication injected with ALDH Bright Cells).
This study will investigate the safety and effect of injecting bone marrow derived stem cells directly into the leg muscle of patients with PAD to help improve blood flow to the muscle and possibly increase the amount of time patients can walk before experiencing leg pain.
Many factors are considered before enrolling patients into a research study. To find enrollment information and answers to your questions please visit the Stem Cell Center.
Learn more about Peripheral Arterial Disease (PAD)
Peripheral Artery Disease (PAD) affects between 8 million and 10 million Americans.
Learn more about peripheral arterial disease and discuss your risks with your doctor. Early detection and treatment make a difference.